NCT04074538 the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
| NCT ID | NCT04074538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ding Ke-Feng |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 55,000 participants |
| Start Date | 2013-01-01 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 55,000 participants in total. It began in 2013-01-01 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
NCRCC study is a national prospective cohort study including colorectal cancer screening population and stage Ⅰ-Ⅳ colorectal cancer patients.
Eligibility Criteria
Inclusion Criteria: * Men and women * Mentally/physically able to consent and participate * Subjects aged ≥18 years old (Colorectal Cancer Patient Cohort, CRCPC), age 40-74 years (CRC Screening Cohort, CRCSC) * Newly-diagnosed colon and rectal cancer for stages Ⅰ-Ⅳ (CRCPC) Exclusion Criteria: * A history of colorectal cancer or bowel resection * Non-Chinese speaking
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04074538 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04074538 currently recruiting?
Yes, NCT04074538 is actively recruiting participants. Contact the research team at dingkefeng@zju.edu.cn for enrollment information.
Where is the NCT04074538 trial being conducted?
This trial is being conducted at Hangzhou, China, Beijing, China, Chengdu, China, Guangzhou, China and 1 additional location.
Who is sponsoring the NCT04074538 clinical trial?
NCT04074538 is sponsored by Ding Ke-Feng. The trial plans to enroll 55,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.